Corrigendum: Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers
Andrea Vannini, Federico Parenti, Cristina Forghieri, Catia Barboni, Anna Zaghini, Gabriella Campadelli-Fiume, Tatiana Gianni
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsVirus-based gene therapy research · Herpesvirus Infections and Treatments · Cytomegalovirus and herpesvirus research
In the published article, the Reference for Lopez and Olive, 2020 was incorrectly written as “Lopez, M., and Olive, D. (2020). Antibodies having specificity to nectin-4 and uses thereof. Google Patents”. It should be “Lopez, M. (2018) Antibodies having specificity to nectin-4 and uses thereof. Google Patents.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.